USA – DFW Neuropathy, a Frisco, TX-based neuropathy treatment company, received investment from HCAP Partners.
The amount of the deal – led by Baymark Partners, a Dallas-based private equity firm – was not disclosed.
The company intends to use the funds to expand their footprint.
Led by CEO Dr. Ali Alavi, DFW Neuropathy is a neuropathy treatment company with four locations in the Dallas–Fort Worth metroplex. The company specializes in Combination Electroanalgesia Treatment to heal or reverse peripheral neuropathy that commonly results from diabetes, impact injuries, or medication damaging the peripheral nerves.05/10/2022
